Er-Bin Zhang
Overview
Explore the profile of Er-Bin Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng Q, Ni Q, Zhu B, Liang X, Ma N, Wang Y, et al.
Oncogene
. 2023 Jul;
42(35):2655-2656.
PMID: 37491607
No abstract available.
2.
Ni Q, Zhu B, Ji Y, Zheng Q, Liang X, Ma N, et al.
Adv Sci (Weinh)
. 2022 Dec;
10(2):e2202448.
PMID: 36453576
The guanine nucleotide exchange factor (GEF) SOS1 catalyzes the exchange of GDP for GTP on RAS. However, regulation of the GEF activity remains elusive. Here, the authors report that PPDPF...
3.
Zheng Q, Ni Q, Zhu B, Liang X, Ma N, Wang Y, et al.
Oncogene
. 2022 Jul;
41(36):4244-4256.
PMID: 35906391
Lung cancer is the most common malignancy and the leading cause of cancer death worldwide, and lung adenocarcinoma (LUAD) is the most prevalent subtype. Considering the emergence of resistance to...
4.
Zhang F, Ni Q, Wang K, Cao H, Guan D, Zhang E, et al.
Cell Mol Gastroenterol Hepatol
. 2022 Apr;
14(1):101-127.
PMID: 35390516
Background & Aims: Hepatocellular carcinoma (HCC) is a highly heterogeneous solid tumor with high morbidity and mortality. AT-rich interaction domain 1A (ARID1A) accounts for up to 10% of mutations in...
5.
Zhang E, Zhang X, Wang K, Zhang F, Chen T, Ma N, et al.
Oncogene
. 2021 Jul;
40(34):5302-5313.
PMID: 34247189
The prognosis of hepatocellular carcinoma (HCC) remains unsatisfactory due to limited effective treatment options. In this work, we investigated the therapeutic efficacy of Terbinafine for HCC and the underlying mechanism....
6.
Ma N, Wang Y, Xu S, Ni Q, Zheng Q, Zhu B, et al.
Nat Commun
. 2021 May;
12(1):3059.
PMID: 34031390
Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver disease in the world, however, no drug treatment has been approved for this disease. Thus, it is urgent...
7.
Jiang H, Cao H, Ma N, Bao W, Wang J, Chen T, et al.
Proc Natl Acad Sci U S A
. 2020 Feb;
117(9):4770-4780.
PMID: 32071245
Recurrence and metastasis remain the major obstacles to successful treatment of hepatocellular carcinoma (HCC). Chromatin remodeling factor ARID2 is commonly mutated in HCC, indicating its important role in cancer development....
8.
Yuan Y, Ma N, Zhang E, Chen T, Jiang H, Yin F, et al.
Oncogene
. 2019 Aug;
38(48):7281-7293.
PMID: 31417183
Bone morphogenetic protein 10 (BMP10), one member of the BMP family, is involved in various development events. Dysregulation of BMP10 has been observed in several diseases, including hypertensive cardiac hypertrophy,...
9.
Gao H, Yin F, Guan D, Feng Y, Zheng Q, Wang X, et al.
Cell Prolif
. 2019 Feb;
52(3):e12583.
PMID: 30793395
Objectives: Wnt1-inducible signalling pathway protein 3 (WISP3/CCN6) belongs to the CCN (CYR61/CTGF/NOV) family of proteins, dysregulation of this family contributed to the tumorigenicity of various tumours. In this study, we...
10.
Zhang X, Jiang Y, Zhong C, Ma N, Zhang E, Zhang F, et al.
Cell Physiol Biochem
. 2018 Jun;
47(4):1643-1654.
PMID: 29945155
Background/aims: Although it has been widely accepted that protein arginine methyltransferase 1 (PRMT1) is a cancer-promoting gene in various cancers, the mechanism of PRMT1 in hepatocellular carcinoma (HCC) requires more...